Cryo-Cell (CCEL) Fundamental Analysis: Revenue, Earnings & Valuation

9.16 / 10

Outperform

Fundamental analysis rates CCEL as Outperform, scoring 9.2/10. Key strengths include PB‑ROE and rising net cash flow per share, while EPS YoY growth is negative. Overall, the company’s fundamentals are solid despite earnings‑growth concerns.

Analysis Checks(4/10)

Revenue-MV

Value0.13

Score0/3

Weight-18.30%

1M Return-6.46%

Net cash flow from operating activities per share (YoY growth rate %)

Value-8.55

Score3/3

Weight24.19%

1M Return5.35%

PB-ROE

Value-0.61

Score3/3

Weight37.40%

1M Return8.31%

Basic earnings per share (YoY growth rate %)

Value-700.00

Score0/3

Weight-5.55%

1M Return-1.82%

Total profit (YoY growth rate %)

Value-183.35

Score0/3

Weight-9.72%

1M Return-3.20%

Net cash flow from operating activities (YoY growth rate %)

Value-8.86

Score3/3

Weight24.65%

1M Return5.57%

Cash-UP

Value-1.19

Score1/3

Weight2.54%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value-700.00

Score0/3

Weight-5.33%

1M Return-1.72%

Asset-MV

Value-0.55

Score3/3

Weight44.87%

1M Return9.13%

Cash-MV

Value-0.24

Score1/3

Weight5.25%

1M Return1.42%

Is CCEL fundamentally strong?

CCEL scores 9.16/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, -7.70% net margin, -10.98 P/E ratio, -1.43 P/B ratio, and -700.00% earnings growth, these metrics solidify its Outperform investment rating.